NCT06781827View on ClinicalTrials.gov

Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

December 30, 2025

Conditions
Inflammatory Bowel Disease
Interventions
DIETARY_SUPPLEMENT

Probiotic

The experimental phase of the study lasts 8 weeks and each patient will be visited 4 times (January, March, June, and December).

DIETARY_SUPPLEMENT

Maltodextrin

The experimental phase of this study had last 8 weeks and each patient will make 4 visits (January, March, June, and December).

Trial Locations (1)

223800

RECRUITING

Gastroenterology Department of Jiangsu Province （Suqian）Hospital, Suqian

All Listed Sponsors
lead

Wecare Probiotics Co., Ltd.

INDUSTRY